Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.
ncRNA
hsa-miR-9-3p
Specific or universal ncRNAs
Universal ncRNAs
Class
MicroRNA
Biomarker
No
Biomarker application
Upstream regulatory factor
Not available
Downstream target
Not available
Differential expression in
recurrence vs. nonrecurrence
Not available
Cancer name
Nasopharyngeal Carcinoma
Alias
Cancer site
Nasopharynx
Recurrence type
Recurrence
Overall survival rate of patients with
high ncRNA expression
Up
ncRNA differential expression in
cancer
patients vs. health people
Not available
Number of patients
137
Male patients
102
Female patients
35
Age range and number
Not available
Recurrence patients
Not available
Recurrence patients male:female
Not available
Recurrence patients age range
Not available
Recurrence mean age
Not available
Sites of recurrence
Not available
Patients without recurrence
Not available
Patients without recurrence male:female
Patients without recurrence age range
Not available
Patients without recurrence mean age
Not available
PMID
Description
After treatment compared with pretreatment, and the four plasma miRNAs were downregulated again at recurrence or metastasis.
Tissue resource
blood samples from NPC and healthy donors
blood samples from NPC and healthy donors
blood samples from NPC and healthy donors
blood samples from NPC and healthy donors
Experiment
qRT-PCR
Institute
the Nanfang Hospital
Country
China
Continent
Asia
Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.